nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR7—Parkinson's disease	0.14	0.191	CbGaD
Asenapine—DRD3—Parkinson's disease	0.132	0.179	CbGaD
Asenapine—DRD1—Parkinson's disease	0.129	0.176	CbGaD
Asenapine—HTR1A—Parkinson's disease	0.107	0.146	CbGaD
Asenapine—DRD2—Parkinson's disease	0.0912	0.124	CbGaD
Asenapine—HTR2A—Parkinson's disease	0.0705	0.0959	CbGaD
Asenapine—CYP2D6—Parkinson's disease	0.0645	0.0877	CbGaD
Asenapine—HTR7—enteric nervous system—Parkinson's disease	0.00405	0.0408	CbGeAlD
Asenapine—HTR7—superior cervical ganglion—Parkinson's disease	0.00387	0.0391	CbGeAlD
Asenapine—HTR7—myenteric nerve plexus—Parkinson's disease	0.00307	0.0309	CbGeAlD
Asenapine—DRD3—telencephalic ventricle—Parkinson's disease	0.00283	0.0286	CbGeAlD
Asenapine—HTR7—locus ceruleus—Parkinson's disease	0.00267	0.027	CbGeAlD
Asenapine—HTR2A—enteric nervous system—Parkinson's disease	0.00253	0.0255	CbGeAlD
Asenapine—HTR5A—forebrain—Parkinson's disease	0.00213	0.0214	CbGeAlD
Asenapine—HTR7—sympathetic nervous system—Parkinson's disease	0.00211	0.0213	CbGeAlD
Asenapine—DRD1—telencephalic ventricle—Parkinson's disease	0.00203	0.0205	CbGeAlD
Asenapine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00191	0.0193	CbGeAlD
Asenapine—HTR2A—locus ceruleus—Parkinson's disease	0.00167	0.0168	CbGeAlD
Asenapine—HTR1B—telencephalic ventricle—Parkinson's disease	0.00164	0.0166	CbGeAlD
Asenapine—HTR1D—telencephalic ventricle—Parkinson's disease	0.00159	0.016	CbGeAlD
Asenapine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00158	0.0159	CbGeAlD
Asenapine—HTR7—pons—Parkinson's disease	0.00154	0.0155	CbGeAlD
Asenapine—HTR7—autonomic nervous system—Parkinson's disease	0.00142	0.0143	CbGeAlD
Asenapine—HTR2A—cerebellar cortex—Parkinson's disease	0.00136	0.0137	CbGeAlD
Asenapine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00133	0.0134	CbGeAlD
Asenapine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00132	0.0133	CbGeAlD
Asenapine—DRD1—nerve—Parkinson's disease	0.00128	0.0129	CbGeAlD
Asenapine—HTR7—telencephalic ventricle—Parkinson's disease	0.00127	0.0128	CbGeAlD
Asenapine—HTR5A—head—Parkinson's disease	0.00122	0.0123	CbGeAlD
Asenapine—DRD2—telencephalic ventricle—Parkinson's disease	0.0012	0.0121	CbGeAlD
Asenapine—HTR5A—nervous system—Parkinson's disease	0.00115	0.0116	CbGeAlD
Asenapine—HTR5A—central nervous system—Parkinson's disease	0.00111	0.0112	CbGeAlD
Asenapine—HTR7—peripheral nervous system—Parkinson's disease	0.00103	0.0103	CbGeAlD
Asenapine—HTR2A—pons—Parkinson's disease	0.000961	0.00969	CbGeAlD
Asenapine—HTR1E—brainstem—Parkinson's disease	0.000941	0.00948	CbGeAlD
Asenapine—HTR1E—forebrain—Parkinson's disease	0.000908	0.00915	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—Parkinson's disease	0.000886	0.00893	CbGeAlD
Asenapine—HTR5A—brain—Parkinson's disease	0.000883	0.0089	CbGeAlD
Asenapine—HTR7—nerve—Parkinson's disease	0.000799	0.00806	CbGeAlD
Asenapine—HTR2A—telencephalic ventricle—Parkinson's disease	0.000791	0.00797	CbGeAlD
Asenapine—DRD2—nerve—Parkinson's disease	0.000756	0.00762	CbGeAlD
Asenapine—ADRA2A—peripheral nervous system—Parkinson's disease	0.000752	0.00758	CbGeAlD
Asenapine—HTR6—forebrain—Parkinson's disease	0.000712	0.00718	CbGeAlD
Asenapine—SLC6A4—hindbrain—Parkinson's disease	0.000706	0.00711	CbGeAlD
Asenapine—HTR2A—peripheral nervous system—Parkinson's disease	0.000639	0.00645	CbGeAlD
Asenapine—HTR1A—hindbrain—Parkinson's disease	0.000626	0.00631	CbGeAlD
Asenapine—HTR7—hindbrain—Parkinson's disease	0.000599	0.00603	CbGeAlD
Asenapine—ADRA1A—hindbrain—Parkinson's disease	0.000578	0.00582	CbGeAlD
Asenapine—DRD2—hindbrain—Parkinson's disease	0.000566	0.00571	CbGeAlD
Asenapine—HRH2—cardiovascular system—Parkinson's disease	0.000551	0.00555	CbGeAlD
Asenapine—DRD1—brainstem—Parkinson's disease	0.000549	0.00554	CbGeAlD
Asenapine—DRD1—forebrain—Parkinson's disease	0.00053	0.00534	CbGeAlD
Asenapine—HTR1E—head—Parkinson's disease	0.00052	0.00524	CbGeAlD
Asenapine—HTR2A—nerve—Parkinson's disease	0.000498	0.00502	CbGeAlD
Asenapine—HTR1E—nervous system—Parkinson's disease	0.000493	0.00497	CbGeAlD
Asenapine—Amoxapine—HTR7—Parkinson's disease	0.000488	0.0949	CrCbGaD
Asenapine—HTR1E—central nervous system—Parkinson's disease	0.000475	0.00478	CbGeAlD
Asenapine—Amoxapine—DRD3—Parkinson's disease	0.000459	0.0893	CrCbGaD
Asenapine—Amoxapine—DRD1—Parkinson's disease	0.00045	0.0876	CrCbGaD
Asenapine—HTR1B—brainstem—Parkinson's disease	0.000445	0.00448	CbGeAlD
Asenapine—DRD4—brain—Parkinson's disease	0.000437	0.0044	CbGeAlD
Asenapine—HTR1D—brainstem—Parkinson's disease	0.000431	0.00434	CbGeAlD
Asenapine—HTR1B—forebrain—Parkinson's disease	0.000429	0.00433	CbGeAlD
Asenapine—Amoxapine—SLC6A3—Parkinson's disease	0.000427	0.0831	CrCbGaD
Asenapine—HTR2C—brainstem—Parkinson's disease	0.000427	0.0043	CbGeAlD
Asenapine—DRD3—head—Parkinson's disease	0.000424	0.00427	CbGeAlD
Asenapine—HTR1D—forebrain—Parkinson's disease	0.000416	0.00419	CbGeAlD
Asenapine—HTR2C—forebrain—Parkinson's disease	0.000412	0.00415	CbGeAlD
Asenapine—HTR6—head—Parkinson's disease	0.000408	0.00411	CbGeAlD
Asenapine—SLC6A4—brainstem—Parkinson's disease	0.000404	0.00408	CbGeAlD
Asenapine—ADRB1—forebrain—Parkinson's disease	0.000404	0.00407	CbGeAlD
Asenapine—DRD3—nervous system—Parkinson's disease	0.000402	0.00405	CbGeAlD
Asenapine—SLC6A4—forebrain—Parkinson's disease	0.00039	0.00393	CbGeAlD
Asenapine—DRD3—central nervous system—Parkinson's disease	0.000387	0.0039	CbGeAlD
Asenapine—HTR6—nervous system—Parkinson's disease	0.000387	0.0039	CbGeAlD
Asenapine—HTR2B—forebrain—Parkinson's disease	0.000387	0.0039	CbGeAlD
Asenapine—Loxapine—HTR7—Parkinson's disease	0.000381	0.0742	CrCbGaD
Asenapine—HTR1E—brain—Parkinson's disease	0.000377	0.0038	CbGeAlD
Asenapine—Amoxapine—HTR1A—Parkinson's disease	0.000374	0.0728	CrCbGaD
Asenapine—HTR2A—hindbrain—Parkinson's disease	0.000373	0.00376	CbGeAlD
Asenapine—HRH2—head—Parkinson's disease	0.000373	0.00376	CbGeAlD
Asenapine—HTR6—central nervous system—Parkinson's disease	0.000372	0.00375	CbGeAlD
Asenapine—HTR1B—cardiovascular system—Parkinson's disease	0.000363	0.00366	CbGeAlD
Asenapine—HTR1A—brainstem—Parkinson's disease	0.000359	0.00362	CbGeAlD
Asenapine—Loxapine—DRD3—Parkinson's disease	0.000358	0.0697	CrCbGaD
Asenapine—HRH2—nervous system—Parkinson's disease	0.000354	0.00356	CbGeAlD
Asenapine—Loxapine—DRD1—Parkinson's disease	0.000352	0.0684	CrCbGaD
Asenapine—HTR1D—cardiovascular system—Parkinson's disease	0.000352	0.00354	CbGeAlD
Asenapine—DRD1—midbrain—Parkinson's disease	0.00035	0.00353	CbGeAlD
Asenapine—HTR1A—forebrain—Parkinson's disease	0.000347	0.00349	CbGeAlD
Asenapine—HTR7—brainstem—Parkinson's disease	0.000343	0.00346	CbGeAlD
Asenapine—ADRB1—cardiovascular system—Parkinson's disease	0.000342	0.00344	CbGeAlD
Asenapine—HRH2—central nervous system—Parkinson's disease	0.00034	0.00343	CbGeAlD
Asenapine—CYP2D6—hindbrain—Parkinson's disease	0.00034	0.00343	CbGeAlD
Asenapine—Loxapine—SLC6A3—Parkinson's disease	0.000333	0.0649	CrCbGaD
Asenapine—HTR7—forebrain—Parkinson's disease	0.000331	0.00334	CbGeAlD
Asenapine—ADRA1A—brainstem—Parkinson's disease	0.000331	0.00334	CbGeAlD
Asenapine—HTR2B—cardiovascular system—Parkinson's disease	0.000327	0.0033	CbGeAlD
Asenapine—DRD2—brainstem—Parkinson's disease	0.000324	0.00327	CbGeAlD
Asenapine—ADRA1A—forebrain—Parkinson's disease	0.000319	0.00322	CbGeAlD
Asenapine—Amoxapine—DRD2—Parkinson's disease	0.000317	0.0618	CrCbGaD
Asenapine—DRD2—forebrain—Parkinson's disease	0.000313	0.00316	CbGeAlD
Asenapine—DRD3—brain—Parkinson's disease	0.000307	0.0031	CbGeAlD
Asenapine—DRD1—head—Parkinson's disease	0.000303	0.00306	CbGeAlD
Asenapine—HTR2C—medulla oblongata—Parkinson's disease	0.000297	0.003	CbGeAlD
Asenapine—HTR6—brain—Parkinson's disease	0.000296	0.00298	CbGeAlD
Asenapine—HTR1A—cardiovascular system—Parkinson's disease	0.000293	0.00295	CbGeAlD
Asenapine—Loxapine—HTR1A—Parkinson's disease	0.000292	0.0568	CrCbGaD
Asenapine—DRD1—nervous system—Parkinson's disease	0.000288	0.0029	CbGeAlD
Asenapine—HTR1B—midbrain—Parkinson's disease	0.000284	0.00286	CbGeAlD
Asenapine—HTR7—cardiovascular system—Parkinson's disease	0.00028	0.00282	CbGeAlD
Asenapine—DRD1—central nervous system—Parkinson's disease	0.000277	0.00279	CbGeAlD
Asenapine—HTR1B—spinal cord—Parkinson's disease	0.000277	0.00279	CbGeAlD
Asenapine—HTR1D—midbrain—Parkinson's disease	0.000275	0.00277	CbGeAlD
Asenapine—HTR2C—midbrain—Parkinson's disease	0.000272	0.00274	CbGeAlD
Asenapine—HRH2—brain—Parkinson's disease	0.00027	0.00272	CbGeAlD
Asenapine—ADRA1A—cardiovascular system—Parkinson's disease	0.00027	0.00272	CbGeAlD
Asenapine—HTR2C—spinal cord—Parkinson's disease	0.000265	0.00267	CbGeAlD
Asenapine—SLC6A4—midbrain—Parkinson's disease	0.000258	0.0026	CbGeAlD
Asenapine—SLC6A4—spinal cord—Parkinson's disease	0.000251	0.00253	CbGeAlD
Asenapine—Loxapine—DRD2—Parkinson's disease	0.000248	0.0482	CrCbGaD
Asenapine—HRH1—forebrain—Parkinson's disease	0.000247	0.00249	CbGeAlD
Asenapine—HTR1B—head—Parkinson's disease	0.000246	0.00248	CbGeAlD
Asenapine—Amoxapine—HTR2A—Parkinson's disease	0.000245	0.0477	CrCbGaD
Asenapine—ADRA2A—forebrain—Parkinson's disease	0.000243	0.00245	CbGeAlD
Asenapine—HTR7—medulla oblongata—Parkinson's disease	0.000239	0.00241	CbGeAlD
Asenapine—HTR1D—head—Parkinson's disease	0.000238	0.0024	CbGeAlD
Asenapine—HTR2C—head—Parkinson's disease	0.000236	0.00238	CbGeAlD
Asenapine—HTR2A—embryo—Parkinson's disease	0.000234	0.00235	CbGeAlD
Asenapine—HTR1B—nervous system—Parkinson's disease	0.000233	0.00235	CbGeAlD
Asenapine—ADRB1—head—Parkinson's disease	0.000231	0.00233	CbGeAlD
Asenapine—HTR1A—midbrain—Parkinson's disease	0.000229	0.00231	CbGeAlD
Asenapine—HTR1D—nervous system—Parkinson's disease	0.000226	0.00227	CbGeAlD
Asenapine—HTR1B—central nervous system—Parkinson's disease	0.000224	0.00226	CbGeAlD
Asenapine—Amoxapine—CYP2D6—Parkinson's disease	0.000224	0.0437	CrCbGaD
Asenapine—HTR2C—nervous system—Parkinson's disease	0.000224	0.00225	CbGeAlD
Asenapine—SLC6A4—head—Parkinson's disease	0.000223	0.00225	CbGeAlD
Asenapine—HTR1A—spinal cord—Parkinson's disease	0.000223	0.00225	CbGeAlD
Asenapine—HTR2B—head—Parkinson's disease	0.000221	0.00223	CbGeAlD
Asenapine—ADRA2C—medulla oblongata—Parkinson's disease	0.00022	0.00222	CbGeAlD
Asenapine—DRD1—brain—Parkinson's disease	0.00022	0.00222	CbGeAlD
Asenapine—ADRB1—nervous system—Parkinson's disease	0.000219	0.00221	CbGeAlD
Asenapine—HTR7—midbrain—Parkinson's disease	0.000219	0.0022	CbGeAlD
Asenapine—HTR1D—central nervous system—Parkinson's disease	0.000217	0.00219	CbGeAlD
Asenapine—HTR2C—central nervous system—Parkinson's disease	0.000215	0.00217	CbGeAlD
Asenapine—HTR2A—brainstem—Parkinson's disease	0.000214	0.00216	CbGeAlD
Asenapine—HTR7—spinal cord—Parkinson's disease	0.000213	0.00215	CbGeAlD
Asenapine—SLC6A4—nervous system—Parkinson's disease	0.000212	0.00214	CbGeAlD
Asenapine—ADRB1—central nervous system—Parkinson's disease	0.000211	0.00213	CbGeAlD
Asenapine—HTR2B—nervous system—Parkinson's disease	0.00021	0.00212	CbGeAlD
Asenapine—DRD2—midbrain—Parkinson's disease	0.000207	0.00208	CbGeAlD
Asenapine—HTR2A—forebrain—Parkinson's disease	0.000207	0.00208	CbGeAlD
Asenapine—SLC6A4—central nervous system—Parkinson's disease	0.000204	0.00206	CbGeAlD
Asenapine—HTR2B—central nervous system—Parkinson's disease	0.000202	0.00204	CbGeAlD
Asenapine—ADRA2C—midbrain—Parkinson's disease	0.000201	0.00203	CbGeAlD
Asenapine—HTR1A—head—Parkinson's disease	0.000198	0.002	CbGeAlD
Asenapine—ADRA2C—spinal cord—Parkinson's disease	0.000196	0.00198	CbGeAlD
Asenapine—CYP2D6—brainstem—Parkinson's disease	0.000195	0.00196	CbGeAlD
Asenapine—Loxapine—HTR2A—Parkinson's disease	0.000192	0.0373	CrCbGaD
Asenapine—HTR7—head—Parkinson's disease	0.00019	0.00191	CbGeAlD
Asenapine—CYP2D6—forebrain—Parkinson's disease	0.000188	0.0019	CbGeAlD
Asenapine—HTR1A—nervous system—Parkinson's disease	0.000188	0.0019	CbGeAlD
Asenapine—ADRA1A—head—Parkinson's disease	0.000183	0.00184	CbGeAlD
Asenapine—HTR1A—central nervous system—Parkinson's disease	0.000181	0.00183	CbGeAlD
Asenapine—HTR7—nervous system—Parkinson's disease	0.00018	0.00181	CbGeAlD
Asenapine—DRD2—head—Parkinson's disease	0.000179	0.00181	CbGeAlD
Asenapine—HTR1B—brain—Parkinson's disease	0.000178	0.0018	CbGeAlD
Asenapine—HTR1A—cerebellum—Parkinson's disease	0.000177	0.00178	CbGeAlD
Asenapine—ADRA2A—medulla oblongata—Parkinson's disease	0.000175	0.00177	CbGeAlD
Asenapine—HTR2A—cardiovascular system—Parkinson's disease	0.000175	0.00176	CbGeAlD
Asenapine—ADRA2C—head—Parkinson's disease	0.000174	0.00176	CbGeAlD
Asenapine—ADRA1A—nervous system—Parkinson's disease	0.000173	0.00175	CbGeAlD
Asenapine—HTR7—central nervous system—Parkinson's disease	0.000173	0.00174	CbGeAlD
Asenapine—HTR1D—brain—Parkinson's disease	0.000173	0.00174	CbGeAlD
Asenapine—HTR2C—brain—Parkinson's disease	0.000171	0.00172	CbGeAlD
Asenapine—DRD2—nervous system—Parkinson's disease	0.00017	0.00171	CbGeAlD
Asenapine—HTR7—cerebellum—Parkinson's disease	0.000169	0.00171	CbGeAlD
Asenapine—ADRB1—brain—Parkinson's disease	0.000168	0.00169	CbGeAlD
Asenapine—ADRA1A—central nervous system—Parkinson's disease	0.000167	0.00168	CbGeAlD
Asenapine—ADRA2C—nervous system—Parkinson's disease	0.000165	0.00167	CbGeAlD
Asenapine—DRD2—central nervous system—Parkinson's disease	0.000164	0.00165	CbGeAlD
Asenapine—ADRA1A—cerebellum—Parkinson's disease	0.000163	0.00164	CbGeAlD
Asenapine—SLC6A4—brain—Parkinson's disease	0.000162	0.00163	CbGeAlD
Asenapine—HTR2B—brain—Parkinson's disease	0.00016	0.00162	CbGeAlD
Asenapine—ADRA2A—midbrain—Parkinson's disease	0.00016	0.00162	CbGeAlD
Asenapine—DRD2—cerebellum—Parkinson's disease	0.00016	0.00161	CbGeAlD
Asenapine—ADRA2C—central nervous system—Parkinson's disease	0.000159	0.0016	CbGeAlD
Asenapine—ADRA2A—spinal cord—Parkinson's disease	0.000156	0.00158	CbGeAlD
Asenapine—ADRA2C—cerebellum—Parkinson's disease	0.000156	0.00157	CbGeAlD
Asenapine—HTR2A—medulla oblongata—Parkinson's disease	0.000149	0.0015	CbGeAlD
Asenapine—HTR1A—brain—Parkinson's disease	0.000144	0.00145	CbGeAlD
Asenapine—HRH1—head—Parkinson's disease	0.000142	0.00143	CbGeAlD
Asenapine—ADRA2A—head—Parkinson's disease	0.000139	0.0014	CbGeAlD
Asenapine—HTR7—brain—Parkinson's disease	0.000137	0.00139	CbGeAlD
Asenapine—HTR2A—midbrain—Parkinson's disease	0.000136	0.00137	CbGeAlD
Asenapine—HRH1—nervous system—Parkinson's disease	0.000134	0.00135	CbGeAlD
Asenapine—HTR2A—spinal cord—Parkinson's disease	0.000133	0.00134	CbGeAlD
Asenapine—ADRA1A—brain—Parkinson's disease	0.000133	0.00134	CbGeAlD
Asenapine—ADRA2A—nervous system—Parkinson's disease	0.000132	0.00133	CbGeAlD
Asenapine—DRD2—brain—Parkinson's disease	0.00013	0.00131	CbGeAlD
Asenapine—HRH1—central nervous system—Parkinson's disease	0.000129	0.0013	CbGeAlD
Asenapine—ADRA2A—central nervous system—Parkinson's disease	0.000127	0.00128	CbGeAlD
Asenapine—ADRA2C—brain—Parkinson's disease	0.000126	0.00127	CbGeAlD
Asenapine—ADRA2A—cerebellum—Parkinson's disease	0.000124	0.00125	CbGeAlD
Asenapine—HTR2A—head—Parkinson's disease	0.000118	0.00119	CbGeAlD
Asenapine—HTR2A—nervous system—Parkinson's disease	0.000112	0.00113	CbGeAlD
Asenapine—HTR2A—central nervous system—Parkinson's disease	0.000108	0.00109	CbGeAlD
Asenapine—CYP2D6—head—Parkinson's disease	0.000108	0.00109	CbGeAlD
Asenapine—HTR2A—cerebellum—Parkinson's disease	0.000106	0.00106	CbGeAlD
Asenapine—CYP3A4—nervous system—Parkinson's disease	0.000104	0.00105	CbGeAlD
Asenapine—HRH1—brain—Parkinson's disease	0.000103	0.00103	CbGeAlD
Asenapine—CYP2D6—nervous system—Parkinson's disease	0.000102	0.00103	CbGeAlD
Asenapine—ADRA2A—brain—Parkinson's disease	0.000101	0.00102	CbGeAlD
Asenapine—CYP3A4—central nervous system—Parkinson's disease	9.99e-05	0.00101	CbGeAlD
Asenapine—CYP2D6—central nervous system—Parkinson's disease	9.83e-05	0.000991	CbGeAlD
Asenapine—CYP2D6—cerebellum—Parkinson's disease	9.61e-05	0.000969	CbGeAlD
Asenapine—HTR2A—brain—Parkinson's disease	8.57e-05	0.000864	CbGeAlD
Asenapine—CYP2D6—brain—Parkinson's disease	7.81e-05	0.000787	CbGeAlD
Asenapine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	4.86e-06	3.02e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	4.85e-06	3.02e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	4.85e-06	3.02e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	4.82e-06	3e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NGF—Parkinson's disease	4.81e-06	2.99e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—APOE—Parkinson's disease	4.81e-06	2.99e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	4.76e-06	2.96e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	4.76e-06	2.96e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	4.76e-06	2.96e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NGF—Parkinson's disease	4.75e-06	2.95e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—APOE—Parkinson's disease	4.73e-06	2.94e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	4.72e-06	2.94e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	4.71e-06	2.93e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	4.71e-06	2.93e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	4.69e-06	2.92e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	4.66e-06	2.9e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	4.66e-06	2.9e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—CASP3—Parkinson's disease	4.6e-06	2.87e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	4.6e-06	2.87e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	4.58e-06	2.85e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling by GPCR—IL6—Parkinson's disease	4.57e-06	2.85e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—COMT—Parkinson's disease	4.57e-06	2.85e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	4.56e-06	2.84e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	4.56e-06	2.84e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	4.56e-06	2.84e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	4.55e-06	2.83e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—MTHFR—Parkinson's disease	4.55e-06	2.83e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—MAOA—Parkinson's disease	4.54e-06	2.83e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	4.53e-06	2.82e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	4.53e-06	2.82e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	4.52e-06	2.81e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	4.51e-06	2.81e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	4.5e-06	2.8e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	4.49e-06	2.79e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MAOB—Parkinson's disease	4.48e-06	2.79e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	4.48e-06	2.79e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	4.42e-06	2.75e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	4.42e-06	2.75e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	4.41e-06	2.74e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	4.36e-06	2.71e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NGF—Parkinson's disease	4.32e-06	2.69e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	4.31e-06	2.68e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	4.28e-06	2.67e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.27e-06	2.65e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—APOE—Parkinson's disease	4.26e-06	2.65e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—APOE—Parkinson's disease	4.24e-06	2.64e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—MAPK8—Parkinson's disease	4.23e-06	2.63e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NGF—Parkinson's disease	4.23e-06	2.63e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—INS—Parkinson's disease	4.22e-06	2.63e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—INS—Parkinson's disease	4.22e-06	2.63e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—APOE—Parkinson's disease	4.2e-06	2.61e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—INS—Parkinson's disease	4.19e-06	2.61e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	4.18e-06	2.6e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.14e-06	2.57e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	4.14e-06	2.57e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	4.12e-06	2.56e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	4.11e-06	2.56e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—DDC—Parkinson's disease	4.11e-06	2.56e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—INS—Parkinson's disease	4.11e-06	2.56e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—CASP3—Parkinson's disease	4.1e-06	2.55e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	4.08e-06	2.54e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—IL6—Parkinson's disease	4.07e-06	2.54e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.07e-06	2.53e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.06e-06	2.53e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—INS—Parkinson's disease	4.04e-06	2.51e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	4.03e-06	2.51e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GPX1—Parkinson's disease	4e-06	2.49e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	4e-06	2.49e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4e-06	2.49e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	3.99e-06	2.48e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	3.95e-06	2.46e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	3.94e-06	2.45e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	3.94e-06	2.45e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	3.93e-06	2.44e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	3.92e-06	2.44e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	3.89e-06	2.42e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.88e-06	2.42e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	3.88e-06	2.42e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CTGF—Parkinson's disease	3.86e-06	2.4e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—INS—Parkinson's disease	3.86e-06	2.4e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	3.85e-06	2.4e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—APOE—Parkinson's disease	3.83e-06	2.38e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	3.81e-06	2.37e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	3.81e-06	2.37e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	3.79e-06	2.36e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	3.77e-06	2.35e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—APOE—Parkinson's disease	3.74e-06	2.33e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	3.7e-06	2.3e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	3.7e-06	2.3e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	3.66e-06	2.28e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	3.64e-06	2.27e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—INS—Parkinson's disease	3.64e-06	2.26e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NGF—Parkinson's disease	3.63e-06	2.26e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—INS—Parkinson's disease	3.62e-06	2.25e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	3.6e-06	2.24e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—INS—Parkinson's disease	3.59e-06	2.23e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	3.58e-06	2.23e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	3.57e-06	2.22e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NGF—Parkinson's disease	3.57e-06	2.22e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NQO1—Parkinson's disease	3.56e-06	2.21e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	3.54e-06	2.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	3.54e-06	2.2e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—TH—Parkinson's disease	3.5e-06	2.18e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	3.5e-06	2.18e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.49e-06	2.17e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.46e-06	2.15e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.46e-06	2.15e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—APOE—Parkinson's disease	3.44e-06	2.14e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	3.39e-06	2.11e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.36e-06	2.09e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	3.33e-06	2.07e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.33e-06	2.07e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—INS—Parkinson's disease	3.27e-06	2.03e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.27e-06	2.03e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	3.25e-06	2.02e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—INS—Parkinson's disease	3.24e-06	2.02e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.21e-06	2e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—INS—Parkinson's disease	3.2e-06	1.99e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.16e-06	1.97e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.16e-06	1.96e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	3.15e-06	1.96e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.14e-06	1.96e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.13e-06	1.95e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	3.13e-06	1.95e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—Parkinson's disease	3.12e-06	1.94e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	3.12e-06	1.94e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.11e-06	1.94e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	3.1e-06	1.93e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	3.1e-06	1.93e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	3.09e-06	1.93e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	3.06e-06	1.9e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	3.05e-06	1.9e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	3.04e-06	1.89e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—INS—Parkinson's disease	3.03e-06	1.88e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NQO1—Parkinson's disease	3.01e-06	1.87e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CASP3—Parkinson's disease	3.01e-06	1.87e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—Parkinson's disease	2.99e-06	1.86e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—COMT—Parkinson's disease	2.98e-06	1.85e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—TH—Parkinson's disease	2.97e-06	1.85e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.97e-06	1.85e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.96e-06	1.84e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—INS—Parkinson's disease	2.94e-06	1.83e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.92e-06	1.82e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	2.89e-06	1.8e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	2.89e-06	1.8e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	2.88e-06	1.79e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	2.87e-06	1.79e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	2.87e-06	1.79e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	2.85e-06	1.78e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.85e-06	1.77e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	2.81e-06	1.75e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.81e-06	1.75e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	2.76e-06	1.72e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—INS—Parkinson's disease	2.75e-06	1.71e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.73e-06	1.7e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	2.71e-06	1.69e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—Parkinson's disease	2.7e-06	1.68e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.7e-06	1.68e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—INS—Parkinson's disease	2.7e-06	1.68e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	2.69e-06	1.67e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.67e-06	1.66e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2.65e-06	1.65e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	2.65e-06	1.65e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	2.64e-06	1.64e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.61e-06	1.62e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.57e-06	1.6e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—COMT—Parkinson's disease	2.52e-06	1.57e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.52e-06	1.57e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.51e-06	1.56e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.51e-06	1.56e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.49e-06	1.55e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.48e-06	1.54e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.46e-06	1.53e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.46e-06	1.53e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	2.43e-06	1.52e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	2.42e-06	1.51e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	2.41e-06	1.5e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.41e-06	1.5e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—Parkinson's disease	2.41e-06	1.5e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	2.4e-06	1.49e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	2.38e-06	1.48e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.38e-06	1.48e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	2.37e-06	1.47e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.35e-06	1.46e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.33e-06	1.45e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.32e-06	1.45e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.32e-06	1.44e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.31e-06	1.44e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.31e-06	1.44e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.3e-06	1.43e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—TH—Parkinson's disease	2.29e-06	1.43e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	2.25e-06	1.4e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—Parkinson's disease	2.24e-06	1.4e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	2.24e-06	1.39e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	2.24e-06	1.39e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	2.22e-06	1.38e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.21e-06	1.38e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.2e-06	1.37e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	2.19e-06	1.36e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.14e-06	1.33e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.13e-06	1.33e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	2.07e-06	1.29e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.04e-06	1.27e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	2.04e-06	1.27e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.03e-06	1.26e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.01e-06	1.25e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.01e-06	1.25e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2e-06	1.24e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.99e-06	1.24e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.97e-06	1.23e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.96e-06	1.22e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.95e-06	1.21e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.94e-06	1.21e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.93e-06	1.2e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—INS—Parkinson's disease	1.92e-06	1.19e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.91e-06	1.19e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—Parkinson's disease	1.9e-06	1.18e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.88e-06	1.17e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.85e-06	1.15e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—Parkinson's disease	1.85e-06	1.15e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.84e-06	1.15e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—Parkinson's disease	1.84e-06	1.15e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.84e-06	1.14e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—Parkinson's disease	1.83e-06	1.14e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.83e-06	1.14e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.82e-06	1.13e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.81e-06	1.13e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.79e-06	1.12e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.78e-06	1.11e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—Parkinson's disease	1.77e-06	1.1e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.71e-06	1.06e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	1.69e-06	1.05e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—INS—Parkinson's disease	1.62e-06	1.01e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.59e-06	9.89e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.57e-06	9.8e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.57e-06	9.76e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—Parkinson's disease	1.47e-06	9.12e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.43e-06	8.89e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.42e-06	8.81e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—Parkinson's disease	1.4e-06	8.7e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.37e-06	8.51e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.36e-06	8.46e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.32e-06	8.23e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INS—Parkinson's disease	1.25e-06	7.79e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.2e-06	7.47e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	7.35e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	7.33e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.16e-06	7.19e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.07e-06	6.68e-06	CbGpPWpGaD
